Seizure control in Unverricht-Lundborg disease: A single-centre study

Epileptic Disorders

Volumn 16, Issue 2, 2014, Pages 191-195

  Roivainen, Reina ^a   Karvonen, Matti K ^b   Puumala, Tarja ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adverse effect; Antiepileptic drug treatment; Prognosis; Progressive myoclonic epilepsy

Indexed keywords

CITALOPRAM; CLONAZEPAM; DIAZEPAM; ESCITALOPRAM; ETIRACETAM; FLUOXETINE; INSULIN; LAMOTRIGINE; LORAZEPAM; METFORMIN; MIANSERIN; MIRTAZAPINE; PHENYTOIN; PIRACETAM; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE;

ADD ON THERAPY; ADULT; ARTICLE; CAUSAL ATTRIBUTION; CLINICAL ARTICLE; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE EXACERBATION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; EMERGENCY TREATMENT; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HUMAN; KIDNEY DYSFUNCTION; LOADING DRUG DOSE; LONG TERM CARE; MALE; MEMORY DISORDER; MIDDLE AGED; MYOCLONUS EPILEPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SEIZURE; SIDE EFFECT; SOMNOLENCE; SPEECH DISORDER; TONIC CLONIC SEIZURE; YOUNG ADULT;

ADVERSE EFFECT; ANTIEPILEPTIC DRUG TREATMENT; PROGNOSIS; PROGRESSIVE MYOCLONIC EPILEPSY;

ADOLESCENT; ADULT; ANTICONVULSANTS; DRUG THERAPY, COMBINATION; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEIZURES; UNVERRICHT-LUNDBORG SYNDROME; YOUNG ADULT;

EID: 84904380991     PISSN: 12949361     EISSN: 19506945     Source Type: Journal    
DOI: 10.1684/epd.2014.0654     Document Type: Article

References (12)

1. Aykutlu E, Baykan B, Gürses C, et al.Add-on therapy with topiramate in progressive myoclonic epilepsy. Epilepsy Behav 2005; 6: 260-3. (Pubitemid 40247163)
2. Crest C, Dupont S, Leguern E, et al. Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients. Neurology 2004; 62: 640-3. (Pubitemid 38252812)
3. Genton P, Gelisse P, Crespel A. Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease. Epilepsia 2006; 47: 2083-5. (Pubitemid 44952261)
4. Iivanainen M, Himberg JJ. Valproate and clonazepam in the treatment of severe progressive myoclonus epilepsy. Arch Neurol 1982; 39: 236-8. (Pubitemid 12190285)
5. Korja M, Kaasinen V, Lamusuo S, et al. Substantial thalamostriatal dopaminergic defect in Univerricht-Lundborg disease. Epilepsia 2007; 48: 1768-73. (Pubitemid 47352864)
6. Koskiniemi M, Van Bleymen B, Hakamies L, et al. Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised double blind, crossover study comparing the efficacy of three dosages of oral piracetam with placebo. J Neurol Neurosurg Psychiatry 1998; 64: 344-8.
7. Kyllerman M, Ben-Menachem E. Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients. Epilepsy Res 1998; 29: 109-14. (Pubitemid 28053878)
8. Magaudda A, Gelisse P, Genton P. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Epilepsia 2004; 45: 678-81. (Pubitemid 38802198)
9. Magaudda A, Ferlazzo E, Nguyen V-H, et al. Unverricht-Lundborg disease, a condition with self-limited progression: long-term follow-up of 20 patients. Epilepsia 2006; 47: 860-6. (Pubitemid 44030180)
10. Santoshkumar B, Turnbull J, Minassian A. Unverricht-Lundborg progressive myoclonus epilepsy in Oman. Pediatr Neurol 2008; 38: 252-5. (Pubitemid 351382125)
11. Shahwan A, Farrell M, Delanty N. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 2005; 4: 239-48. (Pubitemid 40381111)
12. Vossler DG, Conry JA, Murphy JV. Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open-label study. Epileptic Disord 2008; 10: 31-4. doi: 10.1684/epd.2008.0168. (Pubitemid 351507324)